Tinidazol

Tinidazole is an antimicrobial agent in the nitroimidazole class, used to treat certain protozoal infections and anaerobic bacterial infections. It is chemically related to metronidazole but differs in pharmacokinetic properties and dosing.

Mechanism of action: Tinidazole is activated by anaerobic organisms through reduction of its nitro group, producing reactive intermediates that damage DNA and inhibit nucleic acid synthesis. This leads to selective toxicity for many anaerobic bacteria and protozoa.

Medical uses: Tinidazole is used to treat trichomoniasis, giardiasis, and amoebiasis caused by Entamoeba histolytica. It is also utilized for certain anaerobic bacterial infections, including gynecologic and intra-abdominal infections, typically as an alternative when metronidazole is not suitable. Dosing regimens vary by indication and regional guidelines.

Pharmacokinetics: When given orally, tinidazole is rapidly absorbed with peak plasma concentrations reached within a few hours. It has a relatively long elimination half-life (approximately 12–14 hours) and is predominantly cleared by the liver, with metabolites excreted in urine. It can be given orally or by intravenous administration in some settings.

Adverse effects and interactions: Common adverse effects include nausea, a metallic taste, headache, and mild gastrointestinal upset. Less commonly, tinidazole can cause disulfiram-like reactions with alcohol and, with prolonged use, peripheral neuropathy or other neurological symptoms. It should be used with caution in pregnancy and is generally avoided in the first trimester unless clearly indicated.

Society and research: Tinidazole is a widely used antiparasitic and antimicrobial agent with various regional approvals. As with other nitroimidazoles, antimicrobial resistance and interactions with alcohol are considerations in clinical use.